Measuring treatment response to systemic therapy and predicting outcome in biliary tract cancer: comparing tumor size, volume, density, and metabolism

AJR. American Journal of Roentgenology
Dushyant V SahaniAndrew X Zhu

Abstract

The purpose of this study was to evaluate the response of biliary tract cancer treated with multidrug chemotherapy using FDG PET in comparison with morphologic and density changes. In this phase II clinical trial, 28 patients with unresectable or metastatic biliary tract cancers treated with gemcitabine and oxaliplatin combined with bevacizumab (GEMOX-B) underwent FDG PET and contrast-enhanced CT at baseline and after the second cycle of the therapy (8 weeks). A single reviewer recorded tumor maximum standardized uptake value (SUVmax) along with size, volume (3D-sphere), and density. The percentage changes of the parameters were compared with progression-free survival at 7 months. Overall survival was compared with the percentage change of SUVmax. After 8 weeks, measurable reductions (±SD) in size (7.05±4.19 to 5.52±3.28 cm, -21.70%), volume (411.38±540.08 to 212.41±293.45 cm3, -48.36%), and density (60.76±20.65 to 50.68±16.89 HU, -15.59%) were noted along with a substantial drop in SUVmax (5.95±1.95 to 3.36±1.28, -43.52%). The SUVmax change showed positive correlations with tumor size change (R2=0.39, p=0.0004) and volumetric change (R2=0.34, p=0.001). Patients who showed a larger drop in SUVmax at 8 weeks correlated with favo...Continue Reading

Associated Clinical Trials

References

Jan 1, 1981·Cancer·A B MillerA Winkler
May 1, 1994·Seminars in Liver Disease·J N Vauthey, L H Blumgart
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H YoungP Price
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A WeberU Fink
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katja OttWolfgang A Weber
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jun 12, 2004·Seminars in Liver Disease·Yasser Shaib, Hashem B El-Serag
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T AndréUNKNOWN GERCOR Group
Dec 2, 2004·The British Journal of Radiology·B M Seddon, P Workman
Jun 9, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F VerderameF Fulfaro
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 17, 2008·The Oncologist·Annick D Van den Abbeele
May 2, 2008·The Oncologist·Aram F Hezel, Andrew X Zhu
Sep 2, 2008·Critical Reviews in Oncology/hematology·C D MarcusC Hoeffel
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 25, 2009·British Journal of Cancer·T AndréW Scheithauer
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G WillettRakesh K Jain
Feb 5, 2010·The Lancet Oncology·Vanessa N HarryFiona J Gilbert

❮ Previous
Next ❯

Citations

Apr 25, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Oke GerkeWerner Vach
Jan 31, 2018·Nuclear Medicine Communications·Maria I BraghiroliRachel P Riechelmann
May 13, 2020·Journal of Gastrointestinal Cancer·Ali A NasrallahJawad Fares
Mar 4, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jaemin JoYung-Jue Bang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica
N DöbertF Grünwald
© 2021 Meta ULC. All rights reserved